These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 31698798)
41. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Patrick GN; Zukerberg L; Nikolic M; de la Monte S; Dikkes P; Tsai LH Nature; 1999 Dec; 402(6762):615-22. PubMed ID: 10604467 [TBL] [Abstract][Full Text] [Related]
42. CDK5 regulates cell-cell and cell-matrix adhesion in human keratinocytes. Nakano N; Nakao A; Ishidoh K; Tsuboi R; Kominami E; Okumura K; Ogawa H Br J Dermatol; 2005 Jul; 153(1):37-45. PubMed ID: 16029324 [TBL] [Abstract][Full Text] [Related]
43. Focusing on cyclin-dependent kinases 5: A potential target for neurological disorders. Tian Z; Feng B; Wang XQ; Tian J Front Mol Neurosci; 2022; 15():1030639. PubMed ID: 36438186 [TBL] [Abstract][Full Text] [Related]
44. Mutant superoxide dismutase 1 causes motor neuron degeneration independent of cyclin-dependent kinase 5 activation by p35 or p25. Takahashi S; Kulkarni AB J Neurochem; 2004 Mar; 88(5):1295-304. PubMed ID: 15009685 [TBL] [Abstract][Full Text] [Related]
45. A peptide derived from cyclin-dependent kinase activator (p35) specifically inhibits Cdk5 activity and phosphorylation of tau protein in transfected cells. Zheng YL; Li BS; Amin ND; Albers W; Pant HC Eur J Biochem; 2002 Sep; 269(18):4427-34. PubMed ID: 12230554 [TBL] [Abstract][Full Text] [Related]
46. Cyclin-dependent kinase-5 and p35/p25 activators in schizophrenia and major depression prefrontal cortex: basal contents and effects of psychotropic medications. Ramos-Miguel A; Meana JJ; García-Sevilla JA Int J Neuropsychopharmacol; 2013 Apr; 16(3):683-9. PubMed ID: 22964075 [TBL] [Abstract][Full Text] [Related]
47. Association of cyclin-dependent kinase 5 and its activator p35 with apoptotic cell death. Ahuja HS; Zhu Y; Zakeri Z Dev Genet; 1997; 21(4):258-67. PubMed ID: 9438340 [TBL] [Abstract][Full Text] [Related]
48. Metformin Ameliorates Synaptic Defects in a Mouse Model of AD by Inhibiting Cdk5 Activity. Wang Y; Zhao J; Guo FL; Gao X; Xie X; Liu S; Yang X; Yang X; Zhang L; Ye Y; Fan L; Wang J Front Cell Neurosci; 2020; 14():170. PubMed ID: 32670025 [TBL] [Abstract][Full Text] [Related]
49. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation. Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667 [TBL] [Abstract][Full Text] [Related]
50. Special Issue on "Cdk5 and Brain Disorders": Prologue. Kanungo J Brain Disord Ther; 2012; Suppl 1():. PubMed ID: 28066692 [TBL] [Abstract][Full Text] [Related]
51. p25/CDK5 is partially involved in neuronal injury induced by radiofrequency electromagnetic field exposure. Zhang Y; She F; Li L; Chen C; Xu S; Luo X; Li M; He M; Yu Z Int J Radiat Biol; 2013 Nov; 89(11):976-84. PubMed ID: 23786497 [TBL] [Abstract][Full Text] [Related]
53. Cyclin dependent kinase 5 and its interacting proteins in cell death induced in vivo by cyclophosphamide in developing mouse embryos. Zhu Y; Lin L; Kim S; Quaglino D; Lockshin RA; Zakeri Z Cell Death Differ; 2002 Apr; 9(4):421-30. PubMed ID: 11965495 [TBL] [Abstract][Full Text] [Related]
54. p35/cyclin-dependent kinase 5 phosphorylation of ras guanine nucleotide releasing factor 2 (RasGRF2) mediates Rac-dependent Extracellular Signal-regulated kinase 1/2 activity, altering RasGRF2 and microtubule-associated protein 1b distribution in neurons. Kesavapany S; Amin N; Zheng YL; Nijhara R; Jaffe H; Sihag R; Gutkind JS; Takahashi S; Kulkarni A; Grant P; Pant HC J Neurosci; 2004 May; 24(18):4421-31. PubMed ID: 15128856 [TBL] [Abstract][Full Text] [Related]
56. Transforming growth factor-β1 induces cell cycle arrest by activating atypical cyclin-dependent kinase 5 through up-regulation of Smad3-dependent p35 expression in human MCF10A mammary epithelial cells. Park SJ; Yang SW; Kim BC Biochem Biophys Res Commun; 2016 Apr; 472(3):502-7. PubMed ID: 26966064 [TBL] [Abstract][Full Text] [Related]
57. Evidence for amylase release by cyclin-dependent kinase 5 in the rat parotid. Shimomura H; Imai A; Nashida T Arch Biochem Biophys; 2011 Mar; 507(2):310-4. PubMed ID: 21187058 [TBL] [Abstract][Full Text] [Related]
58. Regulation of amyloid precursor protein (APP) phosphorylation and processing by p35/Cdk5 and p25/Cdk5. Liu F; Su Y; Li B; Zhou Y; Ryder J; Gonzalez-DeWhitt P; May PC; Ni B FEBS Lett; 2003 Jul; 547(1-3):193-6. PubMed ID: 12860412 [TBL] [Abstract][Full Text] [Related]
59. Expression of cyclin-dependent kinase 5 and its activator p35 in models of induced apoptotic death in neurons of the substantia nigra in vivo. Neystat M; Rzhetskaya M; Oo TF; Kholodilov N; Yarygina O; Wilson A; El-Khodor BF; Burke RE J Neurochem; 2001 Jun; 77(6):1611-25. PubMed ID: 11413244 [TBL] [Abstract][Full Text] [Related]
60. Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5. Goodyear S; Sharma MC Exp Mol Pathol; 2007 Feb; 82(1):25-32. PubMed ID: 17081516 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]